Clinical Trial Update: Antimalarial Drug Susceptibility and Molecular Characterization of Plasmodium Vivax Isolates in Vietnam [Phase 4]

View source ↗

Summary

Phase 4 trial update from Vietnam assesses antimalarial drug susceptibility and molecular characteristics of Plasmodium vivax isolates; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Vivax Malaria

Snippet

Sponsor: Oxford University Clinical Research Unit, Vietnam | Conditions: Plasmodium Vivax Malaria | Phase 4 | Status: COMPLETED